Unlocking the Potential of PSMD2: A Proteasome 26S Subunit Ubiquitin Receptor for Drug Targeting

Target Name: PSMD2

NCBI ID: G5708

PSMD2

Unlocking the Potential of PSMD2: A Proteasome 26S Subunit Ubiquitin Receptor for Drug Targeting

The ubiquitin system is a protein degradation pathway that plays a crucial role in cell signaling, DNA damage repair, and a variety of other cellular processes. The PSMD2 gene, located on chromosome 16, encodes a protein known as the Proteasome 26S subunit ubiquitin receptor, non-ATPase 2, transcript variant 1 (PSMD2). This protein has been shown to play a critical role in the regulation of ubiquitin homeostasis, and its dysfunction has been implicated in numerous diseases, including cancer. As a result, PSMD2 has emerged as a promising drug target and biomarker for a variety of therapeutic applications.

PSMD2 Functions as a Ubiquitin Receptor

PSMD2 is a 26S subunit of the ubiquitin system, which means it belongs to the 26S subunit of the ubiquitin protein. The 26S subunit is the most abundant subunit of the ubiquitin system and is involved in the formation of ubiquitin chains. PSMD2 functions as a ubiquitin receptor, which allows it to interact with other proteins and participate in various cellular processes.

PSMD2 has been shown to play a critical role in the regulation of ubiquitin homeostasis. Ubiquitin is a protein that targets other proteins for degradation, and its levels are regulated by a complex process that includes the ubiquitin degradation machinery, which includes the 26S subunit of ubiquitin, the ubiquitin activator, and the ubiquitin specificity factor. PSMD2 is one of the key components of the 26S subunit of ubiquitin, and its dysfunction has been linked to the misregulation of ubiquitin homeostasis, which can lead to a variety of cellular consequences.

PSMD2 as a Drug Target

The potential of PSMD2 as a drug target is based on its involvement in the regulation of ubiquitin homeostasis and its association with a variety of diseases. Several studies have shown that PSMD2 is a promising target for small molecule inhibitors, including inhibitors that can inhibit its activity as a ubiquitin receptor. These inhibitors have been shown to have a variety of therapeutic effects, including the inhibition of cancer cell growth, the inhibition of the progression of neurodegenerative diseases, and the regulation of inflammation.

PSMD2 has also been shown to be a potential biomarker for a variety of diseases. The misregulation of ubiquitin homeostasis has been implicated in the development and progression of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. The dysfunction of PSMD2 has been shown to be a common feature of these diseases, and the potential of PSMD2 as a biomarker for these diseases has been demonstrated in several studies.

PSMD2 Interactions with Other Proteins

PSMD2 has been shown to interact with a variety of other proteins, including several key components of the ubiquitin system. The 26S subunit of ubiquitin is a key component of the ubiquitin system, and PSMD2 has been shown to interact with it. The ubiquitin activator is a protein that plays a critical role in the regulation of ubiquitin homeostasis, and PSMD2 has been shown to interact with it. The ubiquitin specificity factor is a protein that recognizes specific ubiquitin sequences and is involved in the regulation of ubiquitin degradation, and PSMD2 has been shown to interact with it.

Conclusion

PSMD2 is a protein that plays a critical role in the regulation of ubiquitin homeostasis and has been implicated in a variety of diseases. Its dysfunction has been associated with the misregulation of

Protein Name: Proteasome 26S Subunit Ubiquitin Receptor, Non-ATPase 2

Functions: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair

The "PSMD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PSMD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets